Over the last year, a lot has changed in the diabetes technology space. Does that ring true for the rankings of the space’s largest companies? Within the last 12 months, we’ve seen one of the industry’s biggest players separate from its parent company. We’ve also seen significant regulatory milestones, product launches and unveilings of next-generation […]
MyLife Diabetes Care
Diabetes Technology Innovations Special Report — 2026
Last year, MassDevice and Drug Delivery Business News rolled out the first edition of their Diabetes Technology Innovations Special Report. Now, we have the second edition available for free download, providing an in-depth overview of where the diabetes industry currently stands after another year of innovation and growth. The diabetes tech industry delivers some of the most advanced combinations of […]
MyLife integrates MyLoop automated insulin pump with Dexcom G7
MyLife Diabetes Care, CamDiab and Dexcom today announced the integration of the G7 continuous glucose monitor (CGM) into the MyLoop system. MyLoop (previously MyLife Loop), an automated insulin delivery (AID) system, is powered by the CamAPS FX app. The system already integrated with the previous-generation Dexcom G6, as well as Abbott’s FreeStyle Libre 3 Plus. […]
MyLife takes on manufacturing responsibility for insulin pumps
MyLife Diabetes Care today announced its next steps as an independent diabetes care technology company. Burgdorf, Switzerland-based MyLife says it has now become the legal manufacturer for MyLife products, as of today, June 1, 2026. It plans to introduce products under the new legal manufacturer to the market in a step-by-step process beginning July 1, […]
MyLife Diabetes Care, Glooko expand partnership
Glooko and MyLife Diabetes Care announced today that they agreed to expand their partnership centered around diabetes management products. Under their agreement, Glooko serves as MyLife Diabetes Care’s primary data management platform for MyLife products. Glooko offers diabetes management platforms such as EndoTool, a leading software platform that offers capabilities for inpatient insulin dosing and […]
MyLife Diabetes Care completes transition to independent company
MyLife Diabetes Care announced that its transition into an independent company has now been formally completed. In August, Ypsomed announced that it completed the sale of its diabetes care business to TecMed AG. With this sale, the company transitioned MyLife from a business unit into a standalone company. This follows a recent medtech trend, with […]
